Follow
Enver Akalin
Enver Akalin
Professor of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine
Verified email at montefiore.org
Title
Cited by
Cited by
Year
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative …
M Haas, A Loupy, C Lefaucheur, C Roufosse, D Glotz, D Seron, ...
American Journal of Transplantation 18 (2), 293-307, 2018
7692018
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
MH Sayegh, E Akalin, WW Hancock, ME Russell, CB Carpenter, ...
The Journal of experimental medicine 181 (5), 1869-1874, 1995
6561995
The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology
A Loupy, M Haas, K Solez, L Racusen, D Glotz, D Seron, BJ Nankivell, ...
American journal of transplantation 17 (1), 28-41, 2017
5762017
Desensitization protocols and their outcome
K Marfo, A Lu, M Ling, E Akalin
Clinical Journal of the American Society of Nephrology 6 (4), 922-936, 2011
2742011
CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous …
SJ Khoury, E Akalin, A Chandraker, LA Turka, PS Linsley, MH Sayegh, ...
The Journal of Immunology 155 (10), 4521-4524, 1995
2311995
Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.
ME Russell, WW Hancock, E Akalin, AF Wallace, T Glysing-Jensen, ...
The Journal of clinical investigation 97 (3), 833-838, 1996
1881996
Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology1
E Akalin, RC Hendrix, RG Polavarapu, TC Pearson, JF Neylan, ...
Transplantation 72 (5), 948-953, 2001
1762001
Cytomegalovirus disease in high‐risk transplant recipients despite ganciclovir or valganciclovir prophylaxis
E Akalin, V Sehgal, S Ames, S Hossain, L Daly, M Barbara, JS Bromberg
American Journal of Transplantation 3 (6), 731-735, 2003
1682003
Post‐liver transplant acute renal failure: factors predicting development of end‐stage renal disease
AS Paramesh, S Roayaie, Y Doan, ME Schwartz, S Emre, T Fishbein, ...
Clinical transplantation 18 (1), 94-99, 2004
1622004
Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses.
WW Hancock, ST Grey, L Hau, E Akalin, C Orthner, MH Sayegh, ...
Transplantation 60 (12), 1525-1532, 1995
1471995
Induction of" infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
K Onodera, M Lehmann, E Akalin, HD Volk, MH Sayegh, ...
The Journal of Immunology 157 (5), 1944-1950, 1996
1371996
Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX study
PF Halloran, J Reeve, E Akalin, O Aubert, GA Bohmig, D Brennan, ...
American Journal of Transplantation 17 (11), 2851-2862, 2017
1172017
Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies
E Akalin, R Dinavahi, R Friedlander, S Ames, G de Boccardo, V Sehgal, ...
Clinical Journal of the American Society of Nephrology 3 (4), 1160-1167, 2008
1052008
Sensitization after kidney transplantation
E Akalin, M Pascual
Clinical journal of the American Society of Nephrology 1 (3), 433-440, 2006
1002006
Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial
BT Lee, S Gabardi, M Grafals, RM Hofmann, E Akalin, A Aljanabi, ...
Clinical Journal of the American Society of Nephrology 9 (3), 583-589, 2014
932014
Gene polymorphisms and transplantation
E Akalin, B Murphy
Current Opinion in Immunology 13 (5), 572-576, 2001
912001
Glomerular infiltration by CXCR3+ ICOS+ activated T cells in chronic allograft nephropathy with transplant glomerulopathy
E Akalin, S Dikman, B Murphy, JS Bromberg, WW Hancock
American Journal of Transplantation 3 (9), 1116-1120, 2003
902003
Antibodies reactive to non-HLA antigens in transplant glomerulopathy
R Dinavahi, A George, A Tretin, E Akalin, S Ames, JS Bromberg, ...
Journal of the American Society of Nephrology 22 (6), 1168-1178, 2011
882011
Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy
E Akalin, SV Ganeshan, J Winston, P Muntner
Transplantation 86 (5), 652-658, 2008
882008
CD28-B7 T CELL COSTIMULATORY BLOCKADE BY CTLA4Ig IN THE RAT RENAL ALLOGRAFT MODEL1, 2: Inhibition of Cell-Mediated and Humoral Immune Responses In Vivo
E Akalin, A Chandraker, ME Russell, LA Turka, WW Hancock, MH Sayegh
Transplantation 62 (12), 1942-1945, 1996
881996
The system can't perform the operation now. Try again later.
Articles 1–20